Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study

Table 4

Comparison of disease activity according to the SLEDAI-2K in the study group.

Comparison with disease activity	SLEDAI <6	SLEDAI ≥6	value
LVEF (%)	56.09 ± 5.18	51.82 ± 7.31	0.0475
IMT AVG (mm)	1.17 ± 0.23	1.20 ± 0.29	0.8949
BMI (kg/m^2)	27.15 ± 5.12	25.94 ± 4.06	0.5571
QRISK®3 (%)	14.57 ± 9.25	17.22 ± 17.20	0.7027
Coriticosteroids	7 (18.42%)	10 (26.31%)	0.6913
TC (mg/dl)	204.76 ± 45.96	206.84 ± 51.34	0.6168
HDL (mg/dl)	65.02 ± 18.17	63.98 ± 20.07	0.9136
LDL (mg/dl)	116.84 ± 47.87	120.16 ± 39.78	0.4687
TG (mg/dl)	117.56 ± 28.61	117.56 ± 41.61	0.6643

LVEF : left ventricular ejection fraction; IMT AVG : carotid intima-media complex thickness average value; BMI : body mass index. QRISK®3: cardiovascular event risk calculator; TC : total cholesterol; HDL: high-density cholesterol; LDL: low-density cholesterol; TG: triglycerides. Source: own studies.